Skip to main content
. 2012 Oct 22;12:193. doi: 10.1186/1472-6882-12-193

Table 2.

Characteristics of adults who used complementary medicine (CM)* to treat their type-2 diabetes

  Did not use CM to treat/manage their diabetes
Used CM to treat/manage their diabetes
 
N Percent S.E.§ N Percent S.E.§
All adults with type-2 diabetes
3873
96.57
0.37
141
3.43
0.37
 
 
N
Percent||
S.E. §
N
Percent||
S.E. §
P-value
Count of diabetes severity measures#
 
 
 
 
 
 
 
0-2 measures
2738
76.82
0.85
97
72.25
4.29
0.284
>=3 measures
904
23.18
0.85
41
27.75
4.29
 
Diabetes duration
 
 
 
 
 
 
 
1-< 5 years
1348
37.2
0.96
45
38.29
5.35
0.067
5-<10 years
835
23.28
0.98
21
15.11
3.58
 
>= 10 years
1536
39.52
1.02
74
46.6
5.33
 
Diabetes medication use
 
 
 
 
 
 
 
None
554
15.83
0.77
26
23.08
4.9
0.16
Any
3273
84.17
0.77
114
76.92
4.9
 
Functional limitation
 
 
 
 
 
 
 
No
3105
83.34
0.7
104
77.34
3.7
0.104
Yes
684
16.66
0.7
37
22.66
3.7
 
Weak/failing kidneys
 
 
 
 
 
 
 
No
3561
93.28
0.49
129
92.38
2.76
0.741
Yes
268
6.72
0.49
11
7.62
2.76
 
Coronary heart disease
 
 
 
 
 
 
 
No
3359
87.95
0.66
130
92.97
2.27
0.044
Yes
447
12.05
0.66
11
7.03
2.27
 
Severe vision problems
 
 
 
 
 
 
 
No
2921
78.91
0.8
105
77.21
4.29
0.706
Yes
874
21.09
0.8
36
22.71
4.29
 
Anxiety or depression
 
 
 
 
 
 
 
No
2800
73.62
0.89
100
72.59
4.82
0.823
Yes
1027
26.38
0.89
41
27.41
4.82
 
Gender
 
 
 
 
 
 
 
Male
1725
49.83
1.04
63
46.95
4.79
0.56
Female
2112
50.17
1.04
78
53.05
4.79
 
Age group
 
 
 
 
 
 
 
Age 18-44 yrs
451
12.54
0.71
22
16.65
4.02
0.04
Age 45-64 yrs
1653
46.71
0.99
73
55.11
4.97
 
Age 65+ yrs
1733
40.75
0.91
46
28.24
4.34
 
Education
 
 
 
 
 
 
 
Less than high school
1190
27.38
0.89
38
23.4
4.17
0.355
At least high school
2594
72.62
0.89
101
76.6
4.17
 
Income
 
 
 
 
 
 
 
$0-$34,999
2334
50.57
1.11
81
44.41
5.37
0.337
$35,000-$74,999
1035
32.05
1.15
40
29.08
5.03
 
$75,000 +
468
17.38
0.99
20
26.51
5.8
 
Race/ethnicity
 
 
 
 
 
 
 
NH White
2183
65.46
0.99
72
59.5
5.46
0.059
NH Black
802
15.9
0.68
20
9.93
2.7
 
Hispanic
650
12.25
0.64
37
19.09
3.42
 
Other races
202
6.39
0.59
12
11.48
4.32
 
Region of residence
 
 
 
 
 
 
 
Northeast
648
16.27
0.78
13
10.09
3.28
0.01
Midwest
846
23.6
1.05
22
16.44
3.9
 
South
1565
40.75
1.11
52
33.89
4.95
 
West
778
19.38
0.9
54
39.58
5.47
 
Health insurance
 
 
 
 
 
 
 
Public insurance
1390
30.43
0.91
39
22.57
4.02
0.135
Private insurance
2096
60.09
1.02
76
63.55
4.91
 
No insurance
342
9.47
0.63
24
13.88
3.46
 
Other health conditions**
 
 
 
 
 
 
 
0-2
2694
70.54
0.93
80
57.84
5.41
0.017
3 or more
1143
29.46
0.93
61
42.16
5.41
 
BMI level
 
 
 
 
 
 
 
BMI 0 - < 25
673
16.3
0.68
14
7.65
2.25
0.002
BMI 25 - < 30
1210
32.08
0.86
41
28.71
4.94
 
BMI >= 30
1954
51.62
0.98
86
63.64
5.08
 
Hypertension
 
 
 
 
 
 
 
No
1544
54.41
1
70
48
5.19
0.297
Yes
2279
57.59
1
71
52
5.19
 
Smoking status
 
 
 
 
 
 
 
Current
605
16.4
0.77
13
11.61
3.99
0.441
Former smoker
1329
35.52
0.99
53
34.51
4.69
 
Never smoker
1878
48.08
1
75
53.89
5.33
 
Alcohol use
 
 
 
 
 
 
 
Never/none
1202
29.19
0.94
40
23.97
3.91
0.21
Any
2604
70.81
0.94
99
76.03
3.91
 
Vigorous leisure activity
 
 
 
 
 
 
 
Unable to do or none
2784
77.82
0.95
93
67.08
5.79
0.086
Any per week
706
22.18
0.95
36
32.92
5.79
 
Perceived health status
 
 
 
 
 
 
 
Fair/poor
1715
43.74
1.02
56
30.35
4.58
0.012
Exc/VG/Good†† 2119 56.26 1.02 85 69.65 4.58  

* CM use, the dependent variable for this study, was defined as use of any of the following in the past 12 months: acupuncture, Ayurveda, biofeedback, chelation therapy, chiropractic care, chiropractic or osteopathic manipulation, energy healing therapy/Reiki, folk medicine, hypnosis, massage therapy, movement based therapies, naturopathy, herbal supplements and other non-vitamin/non-mineral dietary supplements (NVNMDS), homeopathic treatment, diet-based therapies, traditional healers, yoga, tai chi, qi gong, and relaxation techniques.

† The unweighted number of participants belonging to each category.

‡ The denominator used in the calculation of percentages was the number of adults with type-2 Diabetes, defined as all participants with diabetes excluding those who were both diagnosed at age <25 and were currently being treated with insulin, who were classified as having type-1 diabetes. Estimates were age adjusted using the projected 2000 U.S. population as the standard population and using four age groups: 18–24 years, 25–44 years, 45–64 years, and 65 years and over”.

§ Standard Errors.

|| For each individual characteristic, the denominator used in the calculation of percentages was the number of adults with type-2 Diabetes for whom a response was recorded for the particular characteristic. Estimates were age adjusted using the projected 2000 U.S. population as the standard population and using four age groups: 18–24 years, 25–44 years, 45–64 years, and 65 years and over”.

¶ Chi-square analyses comparing individuals with Type-2 diabetes who used CM to treat/manage their diabetes versus those not using CM to treat/manage their diabetes.

# Based on the following six measures: 5 or more years since time of diagnosis, use of insulin or oral hypoglycemic drugs, at least one functional limitation attributed to the diabetes, weak or failing kidneys, Coronary Heart Disease, and severe vision problems.

** Includes all health conditions included in the NHIS except weak or failing kidney, severe vision problems, coronary heart disease, hypertension, and anxiety or depression.

†† Excellent/Very Good/Good.